Wesbanco Bank Inc. Buys 1,831 Shares of Cigna Group $CI

Wesbanco Bank Inc. grew its stake in shares of Cigna Group (NYSE:CI) by 30.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,758 shares of the health services provider’s stock after purchasing an additional 1,831 shares during the period. Wesbanco Bank Inc.’s holdings in Cigna Group were worth $2,069,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in CI. Vanguard Group Inc. boosted its holdings in Cigna Group by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after acquiring an additional 414,834 shares in the last quarter. State Street Corp grew its position in Cigna Group by 1.8% in the 4th quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after purchasing an additional 224,122 shares during the period. Massachusetts Financial Services Co. MA increased its stake in Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after purchasing an additional 903,334 shares in the last quarter. Dodge & Cox increased its stake in Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after purchasing an additional 1,833,389 shares in the last quarter. Finally, Sanders Capital LLC raised its holdings in Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after buying an additional 35,150 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Cantor Fitzgerald lifted their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday, May 1st. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, June 20th. UBS Group raised their price target on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Piper Sandler decreased their price objective on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Finally, Morgan Stanley raised their target price on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average target price of $338.30.

Cigna Group Trading Up 0.3%

NYSE CI opened at $282.84 on Friday. The business’s fifty day moving average is $284.66 and its 200-day moving average is $278.74. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market capitalization of $74.82 billion, a price-to-earnings ratio of 11.99, a PEG ratio of 1.09 and a beta of 0.28. Cigna Group has a one year low of $239.51 and a one year high of $338.89.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were paid a dividend of $1.56 per share. The ex-dividend date was Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.